RAPT Therapeutics (RAPT) Shares Outstanding (Weighted Average) (2020 - 2024)
Historic Shares Outstanding (Weighted Average) for Therapeutics (RAPT) over the last 4 years, with Q3 2024 value amounting to $38.9 million.
- Therapeutics' Shares Outstanding (Weighted Average) rose 142.2% to $38.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $38.9 million, marking a year-over-year increase of 142.2%. This contributed to the annual value of $38.3 million for FY2023, which is 1781.71% up from last year.
- As of Q3 2024, Therapeutics' Shares Outstanding (Weighted Average) stood at $38.9 million, which was up 142.2% from $38.9 million recorded in Q2 2024.
- Over the past 5 years, Therapeutics' Shares Outstanding (Weighted Average) peaked at $38.9 million during Q3 2024, and registered a low of $24.8 million during Q1 2021.
- In the last 4 years, Therapeutics' Shares Outstanding (Weighted Average) had a median value of $33.7 million in 2022 and averaged $33.6 million.
- Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first surged by 2944.66% in 2023, then skyrocketed by 90.08% in 2024.
- Quarter analysis of 4 years shows Therapeutics' Shares Outstanding (Weighted Average) stood at $27.4 million in 2021, then increased by 18.8% to $32.5 million in 2022, then rose by 17.82% to $38.3 million in 2023, then rose by 1.47% to $38.9 million in 2024.
- Its Shares Outstanding (Weighted Average) stands at $38.9 million for Q3 2024, versus $38.9 million for Q2 2024 and $38.6 million for Q1 2024.